On Invalid Date, Better Therapeutics (NASDAQ: BTTX) reported Q2 2023 earnings per share (EPS) of -$0.24, up 42.86% year over year. Total Better Therapeutics earnings for the quarter were -$7.59 million. In the same quarter last year, Better Therapeutics's earnings per share (EPS) was -$0.42.
As of Q3 2023, Better Therapeutics's earnings has grown year over year. Better Therapeutics's earnings in the past year totalled -$37.12 million.
What is BTTX's earnings date?
Better Therapeutics's earnings date is Invalid Date. Add BTTX to your watchlist to be reminded of BTTX's next earnings announcement.
What was BTTX's revenue last quarter?
On Invalid Date, Better Therapeutics (NASDAQ: BTTX) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Better Therapeutics's revenue was $0.00.
What was BTTX's revenue growth in the past year?
As of Q3 2023, Better Therapeutics's revenue has grown null year over year. Better Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.